Early Outpatient Treatment With Remdesivir in Patients at High Risk for Severe COVID-19: A Prospective Cohort Study

BACKGROUND: Early treatment of coronavirus disease 2019 (COVID-19) with remdesivir in high-risk patients, including those with immunosuppression of different causes, has not been evaluated. The objective of this study was to assess the clinical effectiveness of early remdesivir treatment among patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajme-López, Sandra, Martinez-Guerra, Bernardo A, Zalapa-Soto, Jessica, Román-Montes, Carla M, Tamez-Torres, Karla M, González-Lara, María F, Hernandez-Gilosul, Thierry, Kershenobich-Stalnikowitz, David, Sifuentes-Osornio, José, Ponce-de-León, Alfredo, Ruíz-Palacios, Guillermo M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585545/
https://www.ncbi.nlm.nih.gov/pubmed/36285176
http://dx.doi.org/10.1093/ofid/ofac502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585545/
https://www.ncbi.nlm.nih.gov/pubmed/36285176
http://dx.doi.org/10.1093/ofid/ofac502

Ejemplares similares